We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$31.9B
AUM Growth
+$1.95B
Cap. Flow
+$433M
Cap. Flow %
1.36%
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$152M
2
VTR icon
Ventas
VTR
+$139M
3
WMB icon
Williams Companies
WMB
+$122M
4
DOC icon
Healthpeak Properties
DOC
+$100M
5
CVX icon
Chevron
CVX
+$78.1M

Sector Composition

Rank Sector Weight
1 Healthcare 15.93%
2 Consumer Staples 12.47%
3 Energy 12.35%
4 Financials 8.98%
5 Utilities 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRDR
976
DELISTED
BODERFREE INC COM
BRDR
$1.88M 0.01%
+113,441
New +$1.72M
LULU icon
977
lululemon athletica
LULU
$10.6B
$1.88M 0.01%
46,353
FHI icon
978
Federated Hermes
FHI
$4.23B
$1.87M 0.01%
60,574
CYT
979
DELISTED
CYTEC INDS INC
CYT
$1.87M 0.01%
35,510
-250
-0.7% -$12.4K
CLGX
980
DELISTED
Corelogic, Inc.
CLGX
$1.86M 0.01%
61,393
-18,083
-23% -$523K
CIEN icon
981
Ciena
CIEN
$48.3B
$1.86M 0.01%
85,837
-27,858
-25% -$572K
CMC icon
982
Commercial Metals
CMC
$7.28B
$1.86M 0.01%
107,396
+23,356
+28% +$434K
LPNT
983
DELISTED
LifePoint Health, Inc.
LPNT
$1.86M 0.01%
29,917
-1,993
-6% -$117K
WPG
984
DELISTED
Washington Prime Group Inc.
WPG
$1.86M 0.01%
+11,013
New +$1.92M
TECH icon
985
Bio-Techne
TECH
$11.3B
$1.86M 0.01%
80,180
-8,008
-9% -$177K
ASB icon
986
Associated Banc-Corp
ASB
$5.62B
$1.85M 0.01%
102,543
-7,807
-7% -$137K
JNS
987
DELISTED
Janus Capital Group Inc
JNS
$1.85M 0.01%
148,576
+7,154
+5% +$84.2K
NTUS
988
DELISTED
Natus Medical Inc
NTUS
$1.84M 0.01%
73,250
+66,326
+958% +$1.64M
GIII icon
989
G-III Apparel Group
GIII
$1.21B
$1.83M 0.01%
44,874
-26,278
-37% -$992K
ISIL
990
DELISTED
Intersil Corp
ISIL
$1.83M 0.01%
122,392
+36,104
+42% +$492K
WRI
991
DELISTED
Weingarten Realty Investors
WRI
$1.83M 0.01%
55,685
+219
+0.4% +$6.89K
AGN
992
DELISTED
Allergan Inc
AGN
$1.82M 0.01%
10,730
-471,557
-98% -$73.4M
ODP
993
DELISTED
ODP
ODP
$1.81M 0.01%
31,884
-1,635
-5% -$79.7K
APC
994
DELISTED
Anadarko Petroleum
APC
$1.81M 0.01%
16,567
-896
-5% -$91.2K
REX icon
995
REX American Resources
REX
$1.4B
$1.81M 0.01%
148,404
+96,828
+188% +$1.06M
CM icon
996
Canadian Imperial Bank of Commerce
CM
$103B
$1.8M 0.01%
40,294
+14,612
+57% +$635K
ACH
997
Accendra Health
ACH
$82.3M
$1.79M 0.01%
52,692
-2,105
-4% -$72.1K
MYGN icon
998
Myriad Genetics
MYGN
$369M
$1.79M 0.01%
45,991
+317
+0.7% +$11.8K
OGS icon
999
ONE Gas
OGS
$4.81B
$1.77M 0.01%
46,908
+12,806
+38% +$468K
VRN
1000
DELISTED
Veren
VRN
$1.77M 0.01%
43,674
+15,909
+57% +$591K

Similar funds

Federated Hermes's Q2 2014 Portfolio in Review

As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
  • Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
  • Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
  • Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
  • Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
  • Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
  • Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.

Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.